A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background Pantothenate-kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegenerative disorder that is characterized by progressive extrapyramidal signs, visual loss, and cognitive impairment. PKAN is caused by mutations in the pantothenate kinase gene (PANK2), which is located on chromosome 20p13 and encodes pantothenate kinase, the key regulatory enzyme in coenzyme-A biosynthesis. Case Report In this report we describe a case of atypical PKAN with a novel PANK2 mutation, presenting with a 10-year history of postural tremor involving both hands. Upon neurological examination, the patient’s face was masked and he spoke in a monotonous voice. The patient presented with mild bradykinesia and rigidity that involved all of the extremities. Horizontal saccadic eye movements were slow and fragmented. Brain MRI revealed a typical “eyeof-the-tiger” sign. A mutation analysis revealed three PANK2 mutations: two in exon 3 (Asp 378Gly and Leu385CysfsX13) and one in exon 4 (Arg440Pro). Conclusions Parkinsonism is not an unusual presenting symptom in patients with atypical PKAN, and so it is important for physicians to consider PKAN in the differential diagnosis of patients presenting with young-onset parkinsonism.
Abstract
Background Pantothenate-kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegenerative disorder that is characterized by progressive extrapyramidal signs, visual loss, and cognitive impairment. PKAN is caused by mutations in the pantothenate kinase gene (PANK2), which is located on chromosome 20p13 and encodes pantothenate kinase, the key regulatory enzyme in coenzyme-A biosynthesis. Case Report In this report we describe a case of atypical PKAN with a novel PANK2 mutation, presenting with a 10-year history of postural tremor involving both hands. Upon neurological examination, the patient’s face was masked and he spoke in a monotonous voice. The patient presented with mild bradykinesia and rigidity that involved all of the extremities. Horizontal saccadic eye movements were slow and fragmented. Brain MRI revealed a typical “eyeof-the-tiger” sign. A mutation analysis revealed three PANK2 mutations: two in exon 3 (Asp 378Gly and Leu385CysfsX13) and one in exon 4 (Arg440Pro). Conclusions Parkinsonism is not an unusual presenting symptom in patients with atypical PKAN, and so it is important for physicians to consider PKAN in the differential diagnosis of patients presenting with young-onset parkinsonism.
참고문헌 (8)
- Hayflick SJ, "Genetic, clinical, and radiographic delineation of Hallervorden- Spatz syndrome", N Engl J Med, 348, pp.33~40 (2003)
- Zhou B, "A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome", Nat Genet, 28, pp.345~349 (2001)
- Gregory A, "Clinical and genetic delineation of neurodegeneration with brain iron accumulation", J Med Genet, 46, pp.73~80 (2009)
- Thomas M, "Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration", Mov Disord, 19, pp.36~42 (2004)
- Taylor TD, "Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13", Nat Genet, 14, pp.479~481 (1996)
- Hartig MB, "Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation", Ann Neurol, 59, pp.248~256 (2006)
- Kazek B, "A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication", J Child Neurol, 22, pp.1256~1259 (2007)
- onini A, "Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration", Mov Disord, 21, pp.417~418 (2006)